Page last updated: 2024-09-03

6,6'-dicorynomycolyl trehalose and B16 Melanoma

6,6'-dicorynomycolyl trehalose has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Himeno, S; Imagawa, H; Inoue, M; Nagahama, M; Nakano, M; Nishizawa, M; Oda, M; Sakurai, J; Setsu, K; Shibutani, M; Watanabe, N; Yabiku, K; Yamamoto, H1
McGee, JM; Patten, MR; Price, JA; Snyder, D1

Other Studies

2 other study(ies) available for 6,6'-dicorynomycolyl trehalose and B16 Melanoma

ArticleYear
Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate.
    Journal of medicinal chemistry, 2013, Jan-10, Volume: 56, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cord Factors; Glycolipids; Humans; In Vitro Techniques; Lung Neoplasms; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phagocytosis; Stereoisomerism; Structure-Activity Relationship; Trehalose; Xenograft Model Antitumor Assays

2013
Effects of the adjuvant MPL + TDM on tumor challenge in the B16 mouse melanoma model.
    International journal of immunopharmacology, 1996, Volume: 18, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Cord Factors; Lipid A; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured

1996